ANVISA
- Status: likely_approved
🇧🇷 Elrexfio in Brazil
Elrexfio (elranatamab-bcmm) regulatory status in Brazil.
Marketing authorisation
Elrexfio in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Brazil
Frequently asked questions
Is Elrexfio approved in Brazil?
Yes. ANVISA has authorised it.
Who is the marketing authorisation holder for Elrexfio in Brazil?
Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.